| Value | ₹0.62 Cr |
|---|---|
| Order from | Lenus Finvest Private Limited |
BSE filing, BSE: 540204. Summary written from the filing by ALFA Finder's alert engine.
Eiko Lifesciences Ltd: key numbers
- Share price
- ₹50.00
- Market cap
- ₹68.60 Cr
- Revenue (annual)
- ₹52.57 Cr
- Net profit (annual)
- ₹4.50 Cr
- P/E (TTM)
- 14.0×Sector 34.5×
- Promoter holding
- 39.96%+0.05% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eiko Lifesciences Ltd
All →Eiko Lifesciences Other Announcement
The company submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Eiko Lifesciences Annual General Meeting
Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.
Eiko Lifesciences Other Announcement
Eiko Lifesciences informed exchanges that it sent the AGM notice and Annual Report weblink to shareholders who have not registered email addresses.
Eiko Lifesciences Annual General Meeting
Eiko Lifesciences Limited has issued a notice for its 49th Annual General Meeting scheduled for September 22, 2026, to discuss financial statements and related matters.
- Value
- ₹252.3 Cr
Eiko Lifesciences Annual Report
Eiko Lifesciences Limited has announced its 49th Annual General Meeting, scheduled for September 22, 2026. The company has also filed its Annual Report for FY 2025-26.
Eiko Lifesciences Annual General Meeting
Eiko Lifesciences Limited will hold its 49th Annual General Meeting on September 22, 2026, via video conferencing to transact ordinary and special business.
Other convertible warrants announcements
All →Manaksia Coated Metals & Industries Convertible Warrants
Manaksia's monitoring report shows 20 lakh preferential warrants forfeited for unpaid balance, cutting the issue by Rs 9.75 crore. Objects are unfunded for the reduced amount.
- Value
- ₹9.75 Cr
Unifinz Capital India Convertible Warrants
Unifinz's EGM corrigendum seeks approval for up to 98.01 lakh warrants at ₹102 each, worth ₹99.97 Crore. Vikas Goyal's 11.33 lakh warrants are reallocated to Atika Goyal.
- Value
- ₹99.97 Cr
Avalon Technologies Convertible Warrants
Avalon Technologies issued an EGM notice for 21-Nov-2026 to approve convertible warrants via private placement and a related AoA alteration. No monetary value is disclosed in the notice.
Abhinav Leasing & Finance Convertible Warrants
Abhinav Leasing received BSE in-principle approval to issue 6 crore convertible warrants to non-promoters at ₹164 each, raising ₹984 Crore on preferential basis.
- Value
- ₹984.0 Cr
Taylormade Renewables Convertible Warrants
Taylormade Renewables called an EGM on November 18, 2026 to approve issuing up to 14,00,000 warrants to promoters at ₹71.30 each. The issue aggregates about ₹9.98 Crore.
- Value
- ₹9.98 Cr
Embassy Developments Convertible Warrants
Embassy Developments' promoter group entity converted 2.32 crore warrants into equity at INR 111.51 each. The conversion is valued at INR 258.70 crore.
- Value
- ₹258.7 Cr